LP-101

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLP-101
Drug Alias NameLP-101
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsSmall Cell Lung CarcinomaNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Lintonpharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Lintonpharm Co Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A